# Tengjun Biotechnology Corp.

Tengjun Biotechnology Corp. is a company headquartered in Jining, Shandong, China.

## Company overview

- **Legal name:** Tengjun Biotechnology Corp.
- **Former names in filing history:** China Herb Group Holdings Corp (2012-07-26 to 2019-10-25); Island Radio, Inc. (2010-09-16 to 2012-07-17)
- **Classification:** Company
- **Industry (SIC):** 2080 — Beverages
- **Headquarters:** Jining, Shandong, China
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001499785

## About

Tengjun Biotechnology Corp. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001499785, and its reported industry is Beverages. In 10-K filed on 2023-04-17, it reported annual revenue of USD 150,136,738; net income of USD 11,346,841; total assets of USD 58,629,500 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $150.1M (USD 150,136,738)
- **Net income:** $11.3M (USD 11,346,841)
- **Total assets:** $58.6M (USD 58,629,500)
- **Cash and equivalents:** $2.8M (USD 2,830,646)
- **Operating cash flow:** $1.3M (USD 1,347,451)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$747,525 (USD -747,525)
- **Total assets:** $14.0M (USD 14,030,386)
- **Cash and equivalents:** $285,568 (USD 285,568)
- **Operating cash flow:** -$561,297 (USD -561,297)

### FY2020 (period ended 2020-12-31)

- **Net income:** -$53,868 (USD -53,868)
- **Total assets:** $10,240 (USD 10,240)
- **Cash and equivalents:** $5,942 (USD 5,942)
- **Operating cash flow:** -$31,762 (USD -31,762)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-12-31)

- **Net income:** -$59,865 (USD -59,865)
- **Total assets:** $4,299 (USD 4,299)
- **Operating cash flow:** -$39,792 (USD -39,792)

## Recent SEC filings

- Form 8-K — filed 2023-11-17 — period 2023-11-16 — CURRENT REPORT
- Form 8-K — filed 2023-10-10 — period 2023-10-02 — CURRENT REPORT
- Form 8-K — filed 2023-09-29 — period 2023-09-28 — CURRENT REPORT
- Form 10-Q — filed 2023-08-15 — period 2023-06-30 — QUARTERLY REPORT
- Form 8-K — filed 2023-08-14 — period 2023-08-10 — CURRENT REPORT
- Form 8-K — filed 2023-08-07 — period 2023-08-03 — CURRENT REPORT
- Form 10-Q — filed 2023-05-15 — period 2023-03-31 — QUARTERLY REPORT
- Form 8-K — filed 2023-05-08 — period 2023-05-03 — CURRENT REPORT
- Form 10-K — filed 2023-04-17 — period 2022-12-31 — ANNUAL REPORT
- Form 8-K — filed 2023-03-24 — period 2023-03-23 — FORM 8-K
- Form 8-K — filed 2023-01-10 — period 2023-01-09 — CURRENT REPORT
- Form 10-Q — filed 2022-11-14 — period 2022-09-30 — QUARTERLY REPORT

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/tengjun-biotechnology-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology